Istanbul Dentistry School Joins Clinerion’s PRS Platform
Basel, Switzerland – The Dentistry School of the University of Istanbul (IU), Istanbul, Turkey, joins Clinerion’s Patient Recruitment System platform, opening up new patient populations for patient recruitment and new clinical expertise areas for the running of clinical trials.
By joining Patient Recruitment System (PRS), patients at the Dentistry School can be matched to clinical research studies seeking to recruit patients for trials. Pharmaceutical companies using Clinerion’s PRS will be able to evaluate the patient population of the dental hospital during the development of the trial protocol and the site selection steps of their drug trials, potentially bringing more international clinical research to Istanbul University. The hospital itself can rigorously identify and quickly enroll its own patients for trials using PRS.
The IU Dentistry School specializes in all fields of dentistry, from Oral and Maxillofacial Surgery to Prosthodontics, from Periodontology to Pediatric Dentistry, Endodontics to Orthodontics. The hospital treated over 97,500 patients in the past year.
Clinerion’s Patient Recruitment System finds patients for clinical trials by checking clinical trial requirements against patient data from the databases of connected hospitals in real-time. Clinerion’s hospital coverage in Turkey alone currently comprises hospitals in Istanbul, Konya and Malatya with a catchment area of 30 M people. PRS currently has access to over 350 M data entries. Additional use cases for PRS include Market Access Studies and Real World Data Analysis.
“We see a great benefit for our patients as well as for our hospital,” says Prof. Dr. Gülsüm Ak, the Dean of the Dentistry School. “PRS will bring our patients access to innovative new treatments, while the Dentistry School will gain higher exposure and visibility for leading edge clinical research.”
“The Dental Hospital of the University of Istanbul brings PRS new clinical expertise areas for the running of clinical trials and new patient populations for patient recruitment, expanding Clinerion’s hospitals coverage,” says BariÅ ErdoÄan, Clinerion’s Country Head Turkey. “The continued expansion of PRS in Turkey shows the productive and material benefits brought by Clinerion to clinical trials in Turkey.”
“We are thrilled to welcome the Dental Hospital of Istanbul University to the Clinerion PRS platform,” says Ulf Claesson, CEO of Clinerion. “PRS will boost the number, quality and efficiency of their clinical trials activities, while also bringing their patients access to advanced medication.”
For more on Clinerion’s Patient Recruitment System: www.clinerion.com/index/OverviewOurSolutions/PatientRecruitmentSystem
About Clinerion
Clinerion is an international technology services company offering highly scalable electronic patient recruitment solutions to increase efficiency and quality in clinical research. The company's Patient Recruitment System connects to and leverages existing electronic medical records. Following international privacy and confidentiality standards, Clinerion's solutions pseudonymize, enrich and normalize those records and facilitate real-time patient recruitment for clinical trials. Clinerion website: www.clinerion.com
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
